Gilman Shared Info With Tokum Analyst

Jan 30 2014 | 2:36pm ET

A former analyst at Tokum Capital Management told the jury in the Mathew Martoma insider-trading case that he, too, received detailed information about drug trials from Martoma's alleged source.

That source, Sidney Gilman, testified earlier in the trial that he "systematically" shared information about an Alzheimer's drug trial he was overseeing with Martoma. But the former SAC Capital Advisors portfolio manager's lawyers should the jury notes Rene Shen took during a conversation with Gilman in 2008, at around the same time Gilman is said to have tipped Martoma about discouraging results. Shen's notes appear to include information that prosecutors have said, in Martoma's case, was confidential.

Martoma's defense team also question two of their client's former colleagues at SAC. General Counsel Peter Nussbaum completed his testimony, begun on Tuesday, telling the jury that the period of the allegedly illegal trades was one of "extreme anxiety" in the markets, and featured a temporary ban on naked short selling. Nussbaum said he discussed that order from the Securities and Exchange Commission with Cohen.

But, under cross examination, Nussbaum said neither he nor his compliance department were notified about the trades in Elan Corp. and Wyeth LLC in question. And he called into question the defense claim that the trades were made on the recommendation of a former SAC trader, Wayne Holman.

Nussbaum had testified on Tuesday that Holman was under contract to advise Cohen about Wyeth. But he said Holman hadn't been paid for the trades in question, because it was a "losing position."

Another former college, Chandler Bocklage, testified that Cohen regularly consulted with others about healthcare stocks, in addition to Martoma. Bocklage is one of Cohen's closest colleagues at SAC, sitting next to the billionaire for more than a decade, assisting with SAC's so-called Cohen account, which featured the firm's best ideas as vetted by Cohen himself. Bocklage himself said he was Cohen's "right hand man."

But even Bocklage didn't know about the Elan and Wyeth trades, he said. "I was told after the fact that we weren't involved anymore." Bocklage said he thought Cohen told him, "but I'm not sure." Normally, he told the jury, he would have been aware of any trades in the Cohen account, but said he could understand why Cohen wanted to keep it quiet, to hide SAC's trade from other firms.

"I personally think Steve is the greatest trader of all time," Bocklage offered.


In Depth

Why Ponzi Schemes Work: An In-Depth Look At The Allen Stanford Fraud

Dec 21 2014 | 10:30am ET

Texan Allen Stanford first appeared on the radars of financial regulators in 1997...

Lifestyle

Hedgie Funds US Squash Program

Dec 24 2014 | 8:46am ET

Squash, anyone?

Guest Contributor

EidoSearch’s Top Three Market Projections For 2015

Dec 23 2014 | 4:03am ET

It is that time of year again when prognosticators make their big market calls for...

 

Sponsored Content

Editor's Note

    Guidelines for Guest Articles

    Oct 22 2014 | 9:46am ET

    We are always looking for guest articles from hedge fund managers and buy-side firms.

    If you are interested in submitting a contributed piece for possible publication on FINalternatives, please take a look at the specs. Read more…

 

Futures Magazine

December 2014 Cover

Futures 2014 person of the year

Jeff Sprecher was simply looking for a platform to trade energies when launching ICE 14 years ago but it has grown to reach the pinnacle of both the listed futures and equities world.

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.